# OnCo record mast-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/mast-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "mast-therapeutics" ;
  schema:name "Mast Therapeutics"@en ;
  schema:alternateName "Mast Therapeutics, Inc."@en, "ADVENTRX Pharmaceuticals"@en, "Savara"@en ;
  schema:description "Mast, earlier called ADVENTRX, was a San Diego biotech whose fluorouracil modulator CoFactor reached phase 3 in colorectal cancer and failed; it later pursued sickle cell disease and merged into Savara in 2017."@en ;
  schema:url <https://onco.cc/companies/mast-therapeutics/>, <https://savarapharma.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://savarapharma.com>, <https://clinicaltrials.gov/search?lead=Mast%20Therapeutics%2C%20Inc.>, <https://www.wikidata.org/wiki/Q30286592> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/fluorouracil/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .